Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 9, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Reply: To PMID 25002309

Cumali Efe, Dimitrios P Bogdanos

    Digestive Diseases and Sciences
    |June 19, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
    05:51

    A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

    Published on: March 17, 2023

    2.4K
    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
    08:36

    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

    Published on: April 7, 2023

    1.7K

    Related Experiment Videos

    Last Updated: Apr 9, 2026

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
    11:06

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

    Published on: April 7, 2023

    2.9K
    A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
    05:51

    A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

    Published on: March 17, 2023

    2.4K
    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
    08:36

    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

    Published on: April 7, 2023

    1.7K

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Knowledge and perceptions of medical practitioners on the role of nutrition in systemic sclerosis.

    Journal of scleroderma and related disorders·2026
    Same author

    Methodology and quality assurance practices in performing anti-extractable nuclear antigen (ENA) analysis: an EFLM report on an international survey.

    Clinical chemistry and laboratory medicine·2026
    Same author

    Translation and Validation of the Greek Version of the Revised Fibromyalgia Impact Questionnaire (FIQR).

    Mediterranean journal of rheumatology·2026
    Same author

    Apremilast therapy increases CD39<sup>+</sup>CD4<sup>+</sup> T cells in peripheral blood of patients with psoriatic disease: a retrospective observational pilot study.

    Rheumatology international·2026
    Same author

    The new histological criteria for the diagnosis of autoimmune hepatitis.

    Histopathology·2026
    Same author

    Systemic lupus erythematosus is associated with an increased risk for orthorexia nervosa: a cross-sectional study.

    Rheumatology international·2026